Examining the High Cost of the Drug Development Process
The drug development process, beginning with preclinical research up to when the product goes to market, requires time, risk, and high costs.
When FMVs Collide: Coming to Terms with Fair Market Value
With variation in costs between different stakeholders in clinical trials, there is often disagreement on fair market value.
Top 3 Most Read CRO/Sponsor Feature Articles of 2023
Authors highlighted outsourcing and the impact of the COVID-19 pandemic in these CRO/sponsor articles from 2023.
Anticipating Near-Term Structural Change in the Outsourcing Landscape
Can full-service outsourcing to CROs by large biopharma companies sustainably prosecute a clinical development portfolio?
Harmonizing Outsourcing to Keep Clinical Trials on Track
A shared partnership culture is critical in navigating today’s complex terrain.
The Evolution of CRO and Sponsor Relationships
Exploring the 11 key ‘warning signs’ that could impact partnership success.